Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 17 | 2004 | 256 | 0.880 |
Why?
|
| Ambulatory Care | 8 | 2000 | 222 | 0.440 |
Why?
|
| Dyskinesia, Drug-Induced | 8 | 1999 | 22 | 0.390 |
Why?
|
| Antipsychotic Agents | 10 | 2004 | 232 | 0.360 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2000 | 319 | 0.350 |
Why?
|
| Depressive Disorder | 5 | 1999 | 339 | 0.300 |
Why?
|
| Schizophrenic Psychology | 9 | 2000 | 68 | 0.300 |
Why?
|
| Cognition Disorders | 5 | 2004 | 215 | 0.160 |
Why?
|
| Psychotic Disorders | 4 | 2004 | 133 | 0.150 |
Why?
|
| Congenital Abnormalities | 1 | 1997 | 112 | 0.130 |
Why?
|
| Aging | 2 | 2001 | 688 | 0.130 |
Why?
|
| North Carolina | 1 | 2015 | 52 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 1995 | 77 | 0.130 |
Why?
|
| Age Factors | 9 | 2000 | 1092 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 1997 | 317 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 1995 | 192 | 0.110 |
Why?
|
| Neuropsychological Tests | 5 | 2004 | 355 | 0.110 |
Why?
|
| Middle Aged | 19 | 2004 | 12206 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2015 | 213 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 1995 | 171 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2012 | 31 | 0.100 |
Why?
|
| Femoral Vein | 1 | 2012 | 40 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2012 | 85 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 399 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2012 | 102 | 0.100 |
Why?
|
| Male | 23 | 2012 | 25399 | 0.090 |
Why?
|
| Mental Disorders | 1 | 1995 | 395 | 0.090 |
Why?
|
| Humans | 27 | 2015 | 50208 | 0.090 |
Why?
|
| Brief Psychiatric Rating Scale | 5 | 2004 | 7 | 0.090 |
Why?
|
| Aged | 15 | 2004 | 9405 | 0.090 |
Why?
|
| Psychometrics | 4 | 2001 | 224 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 3 | 2004 | 74 | 0.080 |
Why?
|
| Female | 21 | 2012 | 26635 | 0.080 |
Why?
|
| Clonidine | 1 | 1988 | 26 | 0.080 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1988 | 29 | 0.080 |
Why?
|
| Growth Hormone | 1 | 1988 | 96 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2012 | 2379 | 0.070 |
Why?
|
| Smoking | 1 | 1988 | 512 | 0.060 |
Why?
|
| Self Concept | 1 | 2003 | 63 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 1997 | 1185 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2001 | 50 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2004 | 951 | 0.050 |
Why?
|
| Adult | 10 | 2004 | 13324 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 1999 | 112 | 0.050 |
Why?
|
| Mood Disorders | 1 | 1999 | 59 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 1997 | 695 | 0.040 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1999 | 1 | 0.040 |
Why?
|
| Sucrase | 1 | 1999 | 2 | 0.040 |
Why?
|
| Depression | 2 | 2003 | 570 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 189 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 1999 | 564 | 0.030 |
Why?
|
| Age of Onset | 4 | 1999 | 107 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 1999 | 688 | 0.030 |
Why?
|
| Incidence | 2 | 1997 | 1006 | 0.030 |
Why?
|
| Alcoholism | 2 | 1996 | 233 | 0.030 |
Why?
|
| Movement Disorders | 1 | 1995 | 14 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 1995 | 21 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1995 | 156 | 0.030 |
Why?
|
| Video Recording | 1 | 1995 | 80 | 0.030 |
Why?
|
| Observer Variation | 1 | 1995 | 129 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 3 | 0.030 |
Why?
|
| Reference Values | 2 | 2001 | 310 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 410 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1995 | 666 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2004 | 75 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 1541 | 0.030 |
Why?
|
| Comorbidity | 1 | 1995 | 613 | 0.030 |
Why?
|
| Risk Factors | 3 | 1997 | 3629 | 0.030 |
Why?
|
| Sensation | 1 | 1992 | 12 | 0.030 |
Why?
|
| Hip | 1 | 2012 | 25 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 1992 | 26 | 0.030 |
Why?
|
| Rotation | 1 | 2012 | 45 | 0.030 |
Why?
|
| Prevalence | 1 | 1995 | 951 | 0.030 |
Why?
|
| Acute Disease | 2 | 1995 | 368 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2012 | 32 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 65 | 0.030 |
Why?
|
| Sex Factors | 3 | 1999 | 697 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 200 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 1995 | 466 | 0.020 |
Why?
|
| Educational Status | 3 | 1999 | 223 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 418 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 437 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 512 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2004 | 3154 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 319 | 0.020 |
Why?
|
| Irritable Mood | 1 | 1988 | 7 | 0.020 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1988 | 12 | 0.020 |
Why?
|
| Hunger | 1 | 1988 | 15 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1988 | 28 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 1988 | 53 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1422 | 0.020 |
Why?
|
| Random Allocation | 1 | 1988 | 282 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 213 | 0.020 |
Why?
|
| Placebos | 2 | 1999 | 86 | 0.020 |
Why?
|
| Length of Stay | 2 | 2004 | 621 | 0.020 |
Why?
|
| Anxiety | 1 | 1988 | 275 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1998 | 395 | 0.020 |
Why?
|
| Hospitalization | 2 | 2004 | 655 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1988 | 697 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2766 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 1995 | 377 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2000 | 1554 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 1043 | 0.010 |
Why?
|
| Recurrence | 2 | 1995 | 662 | 0.010 |
Why?
|
| Adolescent | 3 | 2004 | 6390 | 0.010 |
Why?
|
| Time Factors | 1 | 1988 | 2922 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 2001 | 3 | 0.010 |
Why?
|
| Self Disclosure | 1 | 2001 | 13 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 889 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 381 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 5 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1999 | 27 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2001 | 223 | 0.010 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1999 | 4 | 0.010 |
Why?
|
| Hydrogen | 1 | 1999 | 13 | 0.010 |
Why?
|
| Breath Tests | 1 | 1999 | 38 | 0.010 |
Why?
|
| Sucrose | 1 | 1999 | 30 | 0.010 |
Why?
|
| Concept Formation | 1 | 1998 | 12 | 0.010 |
Why?
|
| Diarrhea | 1 | 1999 | 92 | 0.010 |
Why?
|
| Milk | 1 | 1999 | 79 | 0.010 |
Why?
|
| Quality of Life | 1 | 2003 | 839 | 0.010 |
Why?
|
| Disease Progression | 1 | 2000 | 831 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 631 | 0.010 |
Why?
|
| California | 1 | 1997 | 87 | 0.010 |
Why?
|
| Learning | 1 | 1998 | 159 | 0.010 |
Why?
|
| Thorax | 1 | 1996 | 16 | 0.010 |
Why?
|
| Tremor | 1 | 1996 | 11 | 0.010 |
Why?
|
| Extremities | 1 | 1996 | 30 | 0.010 |
Why?
|
| Mouth | 1 | 1996 | 33 | 0.010 |
Why?
|
| Face | 1 | 1996 | 60 | 0.010 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1995 | 5 | 0.010 |
Why?
|
| Marital Status | 1 | 1995 | 19 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1995 | 29 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 130 | 0.010 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1995 | 9 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 1954 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 1995 | 38 | 0.010 |
Why?
|
| Thioridazine | 1 | 1994 | 12 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1994 | 44 | 0.010 |
Why?
|
| Haloperidol | 1 | 1994 | 47 | 0.010 |
Why?
|
| Family | 1 | 1995 | 174 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1992 | 78 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1992 | 26 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1992 | 48 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1992 | 97 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1992 | 72 | 0.010 |
Why?
|
| Infant | 1 | 1999 | 3563 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 3883 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 1328 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 2190 | 0.010 |
Why?
|
| Child | 1 | 1999 | 6851 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1998 | 6134 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1995 | 5155 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 13246 | 0.000 |
Why?
|